Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid Neoplasms

NCT00665002 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: WT-1
DRUG: Montanide
DRUG: Sargramostim (GM-CSF)

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]